Medical Communications

Promising Phase 2 data has been released at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 for Sanofi …

Roche says that its Actermra/Roactemra drugs reduce the likelihood that coronavirus patients with virus-related pneumonia will need to be put …

Around one in seven patients who have received Russia’s vaccine against COVID-19 have displayed side-effects in clinical studies, according to …

New York State is suing Johnson & Johnson in a lawsuit seeking $2 billion in damages for the company’s role …

The top ten news stories this week centre around coronavirus vaccines, with Russia signing a deal with an Indian pharma …

Matt Fellows investigates the new challenges facing the oncology space and explores the strategies that can carry it through the disruptive …

Experienced industry executive James Caggiano has been named as the new head of Californian biotech Targazyme, who will take up …

NICE has announced the recommendation of AstraZeneca’s Tagrisso (osimertinib) for routine use on the NHS in England and Wales in …

Novartis and Roche have been fined €444 million in France for abusive practices the companies implemented to push Lucentis over …

It has emerged that NICE has opted to reject Celgene’s Revlimid (lenalidomide) for the maintenance of newly diagnosed multiple myeloma …

The FDA has issued warning letters to 17 websites for illegally selling unapproved or misbranded opioids.  This is due to …

The top 10 news stories this week largely cover COVID-19 vaccines, as hundreds of thousands of people in China have …

President Trump knew how much more deadly coronavirus was than the flu, despite public comments saying that the threat of …

Amarna Therapeutics has announced the appointment of a new Chief Executive Officer (CEO), hiring industry veteran Dr Steen Klysner to …

FibroGen has created the new role of Chief Scientific Officer and appointed Dr Percy Carter to the position, it has …